Literature DB >> 10140764

Factors associated with noncompliance of patients taking antihypertensive medications.

E Shaw1, J G Anderson, M Maloney, S J Jay, D Fagan.   

Abstract

Poor adherence to drug therapy decreases the effectiveness of antihypertensive treatment. Patients must take more than 80% of their antihypertensive drugs to maintain adequate blood pressure control. To understand the incidence of noncompliance and contributing factors, a pilot study was conducted in which a questionnaire was devised and administered to a random sample of 243 hypertensive patients of the adult ambulatory care clinic at Methodist Hospital of Indiana. Ninety-eight patients completed the telephone survey. Demographic data were obtained through chart reviews. The results indicated that 30-46% of the patients were noncompliant with their antihypertensive drug regimens. Factors found to be associated with noncompliance were; employment (P = .0077), use of home remedies (P = .0043), age (P = .0165), experience of side effects (P = .0051), level of concern with missed doses (P = .0043), and cost (P = .014). The incidence of noncompliance in this pilot sample is lower than the estimated 50% noncompliance rate of published data. More research is needed to understand the determinants of noncompliance in order to design interventions to improve compliance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 10140764

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  24 in total

1.  Using the transtheoretical model's stages of change to predict medication adherence in patients with type 2 diabetes mellitus in a primary health care setting.

Authors:  Yara Arafat; Mohamed Izham Mohamed Ibrahim; Ahmed Awaisu; Stephen Colagiuri; Yaw Owusu; Donald E Morisky; Mudather AlHafiz; Ahmed Yousif
Journal:  Daru       Date:  2019-02-07       Impact factor: 3.117

Review 2.  Improving Adherence to Treatment and Reducing Economic Costs of Hypertension: The Role of Olmesartan-Based Treatment.

Authors:  Francesco Vittorio Costa
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-07-10

Review 3.  Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries.

Authors:  Rajesh Vedanthan; Antonio Bernabe-Ortiz; Omarys I Herasme; Rohina Joshi; Patricio Lopez-Jaramillo; Amanda G Thrift; Jacqui Webster; Ruth Webster; Karen Yeates; Joyce Gyamfi; Merina Ieremia; Claire Johnson; Jemima H Kamano; Maria Lazo-Porras; Felix Limbani; Peter Liu; Tara McCready; J Jaime Miranda; Sailesh Mohan; Olugbenga Ogedegbe; Brian Oldenburg; Bruce Ovbiagele; Mayowa Owolabi; David Peiris; Vilarmina Ponce-Lucero; Devarsetty Praveen; Arti Pillay; Jon-David Schwalm; Sheldon W Tobe; Kathy Trieu; Khalid Yusoff; Valentin Fuster
Journal:  Cardiol Clin       Date:  2017-02       Impact factor: 2.213

4.  Actual practice in hypertension: implications for persistence with and effectiveness of therapy.

Authors:  J D Spence; T C Hurley; J D Spence
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

Review 5.  Moxibustion for hypertension: a systematic review.

Authors:  Jong-In Kim; Jun-Yong Choi; Hyangsook Lee; Myeong Soo Lee; Edzard Ernst
Journal:  BMC Cardiovasc Disord       Date:  2010-07-05       Impact factor: 2.298

6.  Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst indigenous and non indigenous people at high cardiovascular risk.

Authors:  Hueiming Liu; Anushka Patel; Alex Brown; Sandra Eades; Noel Hayman; Stephen Jan; Ian Ring; Greg Stewart; Andrew Tonkin; Tarun Weeramanthri; Vicki Wade; Anthony Rodgers; Tim Usherwood; Bruce Neal; David Peiris; Hugh Burke; Christopher Reid; Alan Cass
Journal:  BMC Public Health       Date:  2010-08-05       Impact factor: 3.295

7.  Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors.

Authors:  Philip S Wang; Rhonda L Bohn; Eric Knight; Robert J Glynn; Helen Mogun; Jerry Avorn
Journal:  J Gen Intern Med       Date:  2002-07       Impact factor: 5.128

8.  Lesion of the OVLT markedly attenuates chronic DOCA-salt hypertension in rats.

Authors:  John P Collister; David B Nahey; Rochelle Hartson; Charles E Wiedmeyer; Christopher T Banek; John W Osborn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-06-13       Impact factor: 3.619

9.  Generic versus non-generic formulation of extended-release clarithromycin in patients with community-acquired respiratory tract infections: a prospective, randomized, comparative, investigator-blind, multicentre study.

Authors:  J R Snyman; H S Schoeman; M P Grobusch; M Henning; W Rabie; M Hira; K Parshotam; Y Mithal; S Singh; Z Ramdas
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 10.  Rationale for combination therapy as initial treatment for hypertension.

Authors:  Thomas D Giles
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jul-Aug       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.